Antiviral therapy for human immunodeficiency virus infections.

Clinical Microbiology Reviews
E De Clercq

Abstract

Depending on the stage of their intervention with the viral replicative cycle, human immunodeficiency virus inhibitors could be divided into the following groups: (i) adsorption inhibitors (i.e., CD4 constructs, polysulfates, polysulfonates, polycarboxylates, and polyoxometalates), (ii) fusion inhibitors (i.e., plant lectins, succinylated or aconitylated albumins, and betulinic acid derivatives), (iii) uncoating inhibitors (i.e., bicyclams), (iv) reverse transcription inhibitors acting either competitively with the substrate binding site (i.e., dideoxynucleoside analogs and acyclic nucleoside phosphonates) or allosterically with a nonsubstrate binding site (i.e., non-nucleoside reverse transcriptase inhibitors), (v) integration inhibitors, (vi) DNA replication inhibitors, (vii) transcription inhibitors (i.e., antisense oligodeoxynucleotides and Tat antagonists), (viii) translation inhibitors (i.e., antisense oligodeoxynucleotides and ribozymes), (ix) maturation inhibitors (i.e., protease inhibitors, myristoylation inhibitors, and glycosylation inhibitors), and finally, (x) budding (assembly/release) inhibitors. Current knowledge, including the therapeutic potential, of these various inhibitors is discussed. In view of their pot...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A E GoldfeldS H Speck
May 28, 1992·Biochemical Pharmacology·N CammackJ M Cameron
Nov 1, 1992·Antimicrobial Agents and Chemotherapy·R F SchinaziD C Liotta
Jan 1, 1992·Antisense Research and Development·S Agrawal, J Y Tang
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C BoiziauJ J Toulmé
Feb 1, 1992·AIDS Research and Human Retroviruses·E De Clercq
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P KellamB A Larder
Mar 17, 1992·Biochemical Pharmacology·E Tramontano, Y C Cheng
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C TuerkL Gold
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A KarpasF Hill
Nov 1, 1992·Trends in Genetics : TIG·J Karn, M A Graeble
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J LisziewiczR Gallo
Jun 1, 1992·AIDS Research and Human Retroviruses·R F SchinaziP M Feorino

❮ Previous
Next ❯

Citations

May 20, 1998·Antiviral Research·K KitamuraT Tokunaga
Jul 2, 1999·International Journal of Antimicrobial Agents·L J SmeijstersJ P Overdulve
Oct 23, 1997·Clinical Microbiology Reviews·E De Clercq
Oct 9, 1999·Clinical Microbiology Reviews·M M Cowan
Aug 2, 2003·Biochemical and Biophysical Research Communications·Tieran HanRam P Agarwal
Jan 6, 1999·Antiviral Chemistry & Chemotherapy·M R PlayerP F Torrence
Mar 27, 2004·Nucleosides, Nucleotides & Nucleic Acids·Piyush KumarLeonard I Wiebe
Apr 26, 2001·The American Journal of Chinese Medicine·J A WuC S Yuan
May 15, 2001·Biochemical and Biophysical Research Communications·A S SulemanR A Hudson
Mar 18, 1999·Antiviral Chemistry & Chemotherapy·D DaelemansE De Clercq
Sep 21, 2001·Nucleosides, Nucleotides & Nucleic Acids·F JeannotG Gosselin
Oct 5, 2001·Expert Opinion on Pharmacotherapy·Z Temesgen
Oct 10, 2001·Bioorganic & Medicinal Chemistry Letters·L M TillekeratneR A Hudson
Jan 23, 2016·Frontiers in Microbiology·Kesava Rao V KurapatiMadhavan P N Nair
May 20, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Nathália Oliveira AcésioDenise Crispim Tavares
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·E De Clercq
May 20, 1999·Molecular Membrane Biology·N DüzgüneşM C de Lima
Jan 20, 1997·AIDS Research and Human Retroviruses·K I HashimotoM Baba
Jun 1, 1996·Clinical Obstetrics and Gynecology·L M Mofenson
Mar 30, 2021·Chemical Engineering Journal·Lotfi SellaouiZhuqi Chen
Jun 15, 2010·SAR and QSAR in Environmental Research·R DarnagD Cherqaoui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
R Pauwels, E De Clercq
Medicinal Research Reviews
E De Clercq
© 2021 Meta ULC. All rights reserved